Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an update.
China Isotope & Radiation Corporation announced a potential capital increase for its subsidiary, Chengdu Zhonghe High-Tech Isotope Co., Ltd (CNGT), through a public tender on the China Beijing Equity Exchange. This move aims to address CNGT’s funding needs and optimize its capital structure, supporting business expansion and enhancing operational capabilities. The capital increase is expected to improve the group’s asset quality and risk resilience, although it remains at the preliminary disclosure stage and may not materialize.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation is involved in the development, production, and sales of radioactive isotope products. The company also engages in import-export trade and cargo transportation, with a focus on enhancing its core business and operational capabilities.
Average Trading Volume: 526,764
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.14B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.